SCHEMBL1635281

SCHEMBL1635281

CCOP(=O)(OCC)Sc1cc(S(=O)(=O)NCC(=O)O)ccc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.50
MAPT P10636 1/20 0.47
MEP1B Q16820 1/20 0.45
APEX1 P27695 1/20 0.43
MAPK1 P28482 2/20 0.43
ALDH1A1 P00352 3/20 0.41
TSHR P16473 2/20 0.41
KAT6A Q92794 1/20 0.41
KDM4E B2RXH2 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
KMT2A Q03164 1/20 0.41
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
GRIN3A Q8TCU5 1/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634828 0.90 L3MBTL1 (0.53) L3MBTL1MAPTMEP1BAPEX1MAPK1
SCHEMBL1634504 0.88 L3MBTL1 (0.47) L3MBTL1MAPTMEP1BAPEX1ALDH1A1
SCHEMBL1634552 0.86 L3MBTL1 (0.53) L3MBTL1MAPTMEP1BAPEX1MAPK1
SCHEMBL1635227 0.80 L3MBTL1 (0.52) L3MBTL1MAPTMEP1BAPEX1MAPK1
SCHEMBL1635875 0.79 PDE4A (0.50) L3MBTL1MAPTALDH1A1KDM4EKMT2A
SCHEMBL1634642 0.77 L3MBTL1 (0.55) L3MBTL1MAPTMEP1BAPEX1MAPK1
SCHEMBL1636586 0.77 CA5A (0.39) L3MBTL1ALDH1A1TSHRTDP1GAA
SCHEMBL1634641 0.76 L3MBTL1 (0.56) L3MBTL1MAPTMEP1BAPEX1MAPK1
SCHEMBL1634074 0.74 L3MBTL1 (0.54) L3MBTL1MAPTMEP1BAPEX1MAPK1
SCHEMBL1635731 0.72 GAA (0.34) L3MBTL1ALDH1A1TSHRKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP disclosed
US-7932242-B2 Anticancer agents; radiation and chemical resistance TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-04-26 US disclosed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US disclosed
EP-1740530-A4 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS UNIV TEMPLE (US) 2008-02-27 EP disclosed
EP-1740530-A2 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University of the Commonwealth System of Higher Education (US) 2007-01-10 EP disclosed
WO-2005089269-A2 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2005-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders PCNA, MKI67, TP53 L3MBTL1 2021/4885MAPT 2810/4885MEP1B 3907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.